Effect of streptavidin on cardiac allograft prolongation is due to host T-cell suppression

Transplantation Proceedings

Volumn 37, Issue 1, 2005, Pages 116-118

  Witkowski, P ^a,b,c   Fawwaz, R A ^a   Jin, M X ^a   DePaz, H A ^a   Oluwole, O O ^a   Hardy, M A ^a   Oluwole, S F ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c PandS 17 514 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIBODY; STREPTAVIDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CARDIAC GRAFT REJECTION; CAUSE OF DEATH; CELL PROLIFERATION; COCULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG SCREENING; GRAFT SURVIVAL; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; T LYMPHOCYTE;

EID: 16244374936     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.12.075     Document Type: Conference Paper

References (3)

1. R.A. Fawwaz, O.O. Oluwole, H.A. DePaz Peritransplant streptavidin recipient treatment prolongs rat cardiac allograft survival Transplantation 73 2002 1954
2. K. Ono, E.S. Lindsey Improved technique of heart transplantation in rats J Thorac Cardiovasc Surg 57 1969 225
3. M. Rusckowski, M. Fogarasi, B. Fritz Effect of endogenous biotin on the applications of streptavidin and biotin in mice Nucl Med Biol 24 1997 263